Prestige Consumer Healthcare (PBH) Return on Invested Capital (2014 - 2025)

Prestige Consumer Healthcare's Return on Invested Capital history runs 9 years deep, the most recent figure standing at 0.03% for Q4 2025.

• On a quarterly basis, Return on Invested Capital fell 36.0% year-over-year to 0.03% in Q4 2025; TTM through Dec 2025 was 0.03%, a 36.0% decrease from a year earlier, with the FY2025 full-year figure at 0.21%, down 64.0% from the prior year.
• Return on Invested Capital fell to 0.03% in Q4 2025 per PBH's latest filing, from 0.04% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.39% in Q4 2024 and bottomed at 0.01% in Q4 2023.
• The 5-year median for Return on Invested Capital is 0.07% (2021), against an average of 0.11%.
• Across the five-year window, Return on Invested Capital soared 40 bps in 2024 and slumped 36 bps in 2025, its largest moves.
• Year by year, Return on Invested Capital stood at 0.07% in 2021, then jumped by 41 bps to 0.1% in 2022, then sank by 112 bps to 0.01% in 2023, then jumped by 3330 bps to 0.39% in 2024, then slumped by 93 bps to 0.03% in 2025.
• Per Business Quant, the three latest PBH Return on Invested Capital figures stand at 0.03% (Q4 2025), 0.04% (Q3 2025), and 0.06% (Q2 2025).